Progenitor | Differentiators

		Sub Menu
		Overview
		Differentiators
		Executive Team
		Quality Management Team

Emerging Market Expertise- Global Excellence

When you outsource your drug development program to a Contract Research Organization, you want access to the most experienced team available to assure successful oversight of your project. When your program calls for the emerging market regions, select a group that specializes in the intricacies of such a program and has a demonstrated track record of success in these regions.

Progenitor International Research provides a unique combination of extensive expertise from first-in-class teams committed to the success of your global program. Together, we can help you to minimize your risks by diversifying your approach to the emerging markets.

The key points that differentiate Progenitor International Research from other global Contract Research Organizations offering emerging market solutions are:


	Commitment to emerging market solutions. Focused expertise in these regions allows for committed approach to success in these regions.

	Better access to experienced staff.

	Quality assurance teams located in the emerging markets (Japan, China, India, and South Africa).

	In-depth Phase I-IV emerging market experience with over 500 studies in the last five years working with top pharmaceutical companies with numerous successful sponsor audits.

	Better value in terms of pricing compared to our competitors due to the overhead structure of our global group. We pride ourselves in offering the convenience of a global CRO for key emerging markets, while maintaining the value of these markets for our customers.

	Therapeutic specialists in each region who have expert knowledge and relationships with key physicians in their local markets.

	Scientific, medical and regulatory consultation based upon global drug development expertise.